Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.
📌 Upstart $UPST — Dave Girouard purchased $5.00...
Today's trade is in a mental health biotech company focused on developing psychedelic-assisted therapies — primarily a synthetic form of psilocybin called COMP360 — for difficult-to-treat psychiatric conditions.
Every weekend, I dig into our filings tracker looking for the biggest conviction buys — and this week, the size and quality of the buyers really stood out.
